US Patent Issued to Galderma Holding on July 29 for "Post-crosslinking partial degradation of amide crosslinked hydrogels" (Swedish Inventor)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,513, issued on July 29, was assigned to Galderma Holding SA (Zug, Switzerland).

"Post-crosslinking partial degradation of amide crosslinked hydrogels" was invented by Johan Olsson (Bromma, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a method of preparing a hydrogel product comprising crosslinked glycosaminoglycan molecules at a concentration Cfinal (mg/mL). The method comprising the steps of: a) crosslinking a glycosaminoglycan having a molecular weight of above 700 kDa in conditions so as to provide a glycosaminoglycan hydrogel crosslinked by amide bonds and having a Cmin (mg/mL) that is above Cfinal/2, whe...